Evidence map›Paper›PMID 32354333›Full record

ArticleMalaria journal2020

Intensity of pyrethroid resistance in Anopheles gambiae before and after a mass distribution of insecticide-treated nets in Kinshasa and in 11 provinces of the Democratic Republic of Congo.

Francis Wat'senga, Fiacre Agossa, Emile Z Manzambi, Gillon Illombe, Tania Mapangulu, Tamfum Muyembe, Tiffany Clark, Mame Niang, Ferdinand Ntoya, Aboubacar Sadou and 6 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Characterizing pyrethroid resistance and mechanisms inCurrent research in parasitology & vector-borne diseases · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Francis Wat'sengaInstitut National de Recherche Biomédicale, PO Box 1192, Kinshasa, Democratic Republic of Congo.
Fiacre AgossaUSAID President's Malaria Initiative, VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Emile Z ManzambiInstitut National de Recherche Biomédicale, PO Box 1192, Kinshasa, Democratic Republic of Congo.
Gillon IllombeInstitut National de Recherche Biomédicale, PO Box 1192, Kinshasa, Democratic Republic of Congo.
Tania MapanguluInstitut National de Recherche Biomédicale, PO Box 1192, Kinshasa, Democratic Republic of Congo.
Tamfum MuyembeInstitut National de Recherche Biomédicale, PO Box 1192, Kinshasa, Democratic Republic of Congo.
Tiffany ClarkUSAID President's Malaria Initiative, VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Mame NiangU.S. President's Malaria Initiative, U.S. Agency for International Development, Kinshasa, Democratic Republic of the Congo.
Ferdinand NtoyaU.S. President's Malaria Initiative, U.S. Agency for International Development, Kinshasa, Democratic Republic of the Congo.
Aboubacar SadouU.S. President's Malaria Initiative, U.S. Agency for International Development, Kinshasa, Democratic Republic of the Congo.
Mateusz PlucinskiU.S. President's Malaria Initiative and Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
Yikun LiU.S. President's Malaria Initiative and Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
Louisa A MessengerU.S. President's Malaria Initiative and Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
Christen FornadelU.S. President's Malaria Initiative, United States Agency for International Development, Bureau for Global Health, Office of Infectious Disease, 2100 Crystal Drive, Arlington, VA, 22202, USA.
Richard M OxboroughUSAID President's Malaria Initiative, VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Seth R IrishU.S. President's Malaria Initiative and Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30329, USA. xjs7@cdc.gov.
National Institute of Biomedical Research · CDU.S. President's Malaria Initiative · USAbt Global (United States) · USCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBetween 2011 and 2018, an estimated 134.8 million pyrethroid-treated long-lasting insecticidal nets (LLINs) were distributed nationwide in the Democratic Republic of Congo (DRC) for malaria control. Pyrethroid resistance has developed in DRC in recent years, but the intensity of resistance and impact on LLIN efficacy was not known. Therefore, the intensity of resistance of Anopheles gambiae sensu lato (s.l.) to permethrin and deltamethrin was monitored before and after a mass distribution of LLINs in Kinshasa in December 2016, and in 6 other sites across the country in 2017 and 11 sites in 2018.

methodsIn Kinshasa, CDC bottle bioassays using 1, 2, 5, and 10 times the diagnostic dose of permethrin and deltamethrin were conducted using An. gambiae s.l. collected as larvae and reared to adults. Bioassays were conducted in four sites in Kinshasa province 6 months before a mass distribution of deltamethrin-treated LLINs and then two, six, and 10 months after the distribution. One site in neighbouring Kongo Central province was used as a control (no mass campaign of LLIN distribution during the study). Nationwide intensity assays were conducted in six sites in 2017 using CDC bottle bioassays and in 11 sites in 2018 using WHO intensity assays. A sub-sample of An. gambiae s.l. was tested by PCR to determine species composition and frequency of kdr-1014F and 1014S alleles.

resultsIn June 2016, before LLIN distribution, permethrin resistance intensity was high in Kinshasa; the mean mortality rate was 43% at the 5× concentration and 73% at the 10× concentration. Bioassays at 3 time points after LLIN distribution showed considerable variation by site and time and there was no consistent evidence for an increase in pyrethroid resistance intensity compared to the neighbouring control site. Tests of An. gambiae s.l. in 6 sites across the country in 2017 and 11 sites in 2018 showed all populations were resistant to the diagnostic doses of 3 pyrethroids. In 2018, the intensity of resistance varied by site, but was generally moderate for all three pyrethroids, with survivors at ×5 the diagnostic dose. Anopheles gambiae sensu stricto (s.s.) was the most common species identified across 11 sites in DRC, but in Kinshasa, An. gambiae s.s. (91%) and Anopheles coluzzii (8%) were sympatric.

conclusionsModerate or high intensity pyrethroid resistance was detected nationwide in DRC and is a serious threat to sustained malaria control with pyrethroid LLINs. Next generation nets (PBO nets or bi-treated nets) should be considered for mass distribution.

Indexed as

Insecticide ResistanceAnimalsAnophelesDemocratic Republic of the CongoFemaleInsecticidesInsecticide-Treated BednetsNitrilesPermethrinPyrethrinsdecamethrinInsecticidesNitrilesPermethrinPyrethrinsAnopheles gambiaeCDC bottle bioassayDemocratic Republic of CongoPyrethroidResistance intensityWHO susceptibility test

Identifiers

PMID32354333
PMCPMC7193383
OpenAlexW3022255532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.